nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRFAM7A—corpus luteum—hypothyroidism	0.102	0.232	CbGeAlD
Varenicline—CHRNA7—corpus luteum—hypothyroidism	0.0822	0.188	CbGeAlD
Varenicline—CHRNA4—cochlea—hypothyroidism	0.0455	0.104	CbGeAlD
Varenicline—CHRNA4—nerve—hypothyroidism	0.0183	0.0418	CbGeAlD
Varenicline—CHRNB2—adrenal cortex—hypothyroidism	0.0112	0.0257	CbGeAlD
Varenicline—CHRNB2—heart—hypothyroidism	0.0109	0.0248	CbGeAlD
Varenicline—CHRNA6—cerebellum—hypothyroidism	0.0108	0.0247	CbGeAlD
Varenicline—Angina pectoris—Liothyronine—hypothyroidism	0.0104	0.0213	CcSEcCtD
Varenicline—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00936	0.0192	CcSEcCtD
Varenicline—Myocardial infarction—Liothyronine—hypothyroidism	0.00931	0.0191	CcSEcCtD
Varenicline—CHRNB2—pituitary gland—hypothyroidism	0.00908	0.0208	CbGeAlD
Varenicline—Intestinal obstruction—Liotrix—hypothyroidism	0.00899	0.0185	CcSEcCtD
Varenicline—CHRNB2—adrenal gland—hypothyroidism	0.00811	0.0185	CbGeAlD
Varenicline—CHRNB2—blood—hypothyroidism	0.00811	0.0185	CbGeAlD
Varenicline—CHRNA3—adrenal gland—hypothyroidism	0.00787	0.018	CbGeAlD
Varenicline—CHRNB2—thyroid gland—hypothyroidism	0.00783	0.0179	CbGeAlD
Varenicline—Arrhythmia—Liothyronine—hypothyroidism	0.00761	0.0157	CcSEcCtD
Varenicline—CHRNB2—female gonad—hypothyroidism	0.00757	0.0173	CbGeAlD
Varenicline—Tenderness—Liotrix—hypothyroidism	0.00703	0.0145	CcSEcCtD
Varenicline—CHRNA7—heart—hypothyroidism	0.00689	0.0157	CbGeAlD
Varenicline—Disorientation—Dextrothyroxine—hypothyroidism	0.00676	0.0139	CcSEcCtD
Varenicline—Disorientation—Levothyroxine—hypothyroidism	0.00676	0.0139	CcSEcCtD
Varenicline—CHRNB2—testis—hypothyroidism	0.00671	0.0153	CbGeAlD
Varenicline—CHRNA3—testis—hypothyroidism	0.00651	0.0149	CbGeAlD
Varenicline—CHRNA7—cardiovascular system—hypothyroidism	0.0065	0.0148	CbGeAlD
Varenicline—Increased appetite—Levothyroxine—hypothyroidism	0.00644	0.0132	CcSEcCtD
Varenicline—Increased appetite—Dextrothyroxine—hypothyroidism	0.00644	0.0132	CcSEcCtD
Varenicline—CHRNA4—cardiovascular system—hypothyroidism	0.00641	0.0146	CbGeAlD
Varenicline—Hypertension—Liothyronine—hypothyroidism	0.00641	0.0132	CcSEcCtD
Varenicline—CHRFAM7A—blood—hypothyroidism	0.00636	0.0145	CbGeAlD
Varenicline—CHRNB2—liver—hypothyroidism	0.00634	0.0145	CbGeAlD
Varenicline—Hypoglycaemia—Levothyroxine—hypothyroidism	0.0062	0.0128	CcSEcCtD
Varenicline—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.0062	0.0128	CcSEcCtD
Varenicline—CHRNB2—cerebellum—hypothyroidism	0.0062	0.0142	CbGeAlD
Varenicline—CHRFAM7A—thyroid gland—hypothyroidism	0.00614	0.014	CbGeAlD
Varenicline—CHRNA3—cerebellum—hypothyroidism	0.00601	0.0137	CbGeAlD
Varenicline—Affect lability—Levothyroxine—hypothyroidism	0.00595	0.0122	CcSEcCtD
Varenicline—Affect lability—Dextrothyroxine—hypothyroidism	0.00595	0.0122	CcSEcCtD
Varenicline—CHRFAM7A—female gonad—hypothyroidism	0.00593	0.0136	CbGeAlD
Varenicline—Tachycardia—Liothyronine—hypothyroidism	0.00591	0.0122	CcSEcCtD
Varenicline—Irritability—Dextrothyroxine—hypothyroidism	0.00577	0.0119	CcSEcCtD
Varenicline—Irritability—Levothyroxine—hypothyroidism	0.00577	0.0119	CcSEcCtD
Varenicline—Mood swings—Dextrothyroxine—hypothyroidism	0.00573	0.0118	CcSEcCtD
Varenicline—Mood swings—Levothyroxine—hypothyroidism	0.00573	0.0118	CcSEcCtD
Varenicline—Hypotension—Liothyronine—hypothyroidism	0.00566	0.0116	CcSEcCtD
Varenicline—CHRFAM7A—testis—hypothyroidism	0.00526	0.012	CbGeAlD
Varenicline—Dysphagia—Dextrothyroxine—hypothyroidism	0.00523	0.0108	CcSEcCtD
Varenicline—Dysphagia—Levothyroxine—hypothyroidism	0.00523	0.0108	CcSEcCtD
Varenicline—CHRNA7—adrenal gland—hypothyroidism	0.00514	0.0117	CbGeAlD
Varenicline—CHRNA7—blood—hypothyroidism	0.00514	0.0117	CbGeAlD
Varenicline—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00509	0.0105	CcSEcCtD
Varenicline—Angina pectoris—Levothyroxine—hypothyroidism	0.00509	0.0105	CcSEcCtD
Varenicline—CHRNA4—adrenal gland—hypothyroidism	0.00507	0.0116	CbGeAlD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00498	0.0653	CbGpPWpGaD
Varenicline—Disorientation—Liotrix—hypothyroidism	0.00497	0.0102	CcSEcCtD
Varenicline—CHRNA7—thyroid gland—hypothyroidism	0.00496	0.0113	CbGeAlD
Varenicline—Renal failure acute—Liotrix—hypothyroidism	0.00482	0.00991	CcSEcCtD
Varenicline—CHRNA7—female gonad—hypothyroidism	0.00479	0.011	CbGeAlD
Varenicline—Body temperature increased—Liothyronine—hypothyroidism	0.00479	0.00985	CcSEcCtD
Varenicline—Increased appetite—Liotrix—hypothyroidism	0.00474	0.00974	CcSEcCtD
Varenicline—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.0046	0.00945	CcSEcCtD
Varenicline—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.0046	0.00945	CcSEcCtD
Varenicline—Myocardial infarction—Levothyroxine—hypothyroidism	0.00457	0.0094	CcSEcCtD
Varenicline—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00457	0.0094	CcSEcCtD
Varenicline—Hypoglycaemia—Liotrix—hypothyroidism	0.00456	0.00938	CcSEcCtD
Varenicline—Cerebrovascular accident—Liotrix—hypothyroidism	0.00454	0.00934	CcSEcCtD
Varenicline—Affect lability—Liotrix—hypothyroidism	0.00438	0.00901	CcSEcCtD
Varenicline—CHRNA7—testis—hypothyroidism	0.00425	0.00971	CbGeAlD
Varenicline—Irritability—Liotrix—hypothyroidism	0.00425	0.00874	CcSEcCtD
Varenicline—Mood swings—Liotrix—hypothyroidism	0.00422	0.00867	CcSEcCtD
Varenicline—Hypokalaemia—Liotrix—hypothyroidism	0.00405	0.00833	CcSEcCtD
Varenicline—CHRNA4—cerebellum—hypothyroidism	0.00387	0.00885	CbGeAlD
Varenicline—Abdominal distension—Liotrix—hypothyroidism	0.00387	0.00796	CcSEcCtD
Varenicline—Dysphagia—Liotrix—hypothyroidism	0.00385	0.00791	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00378	0.0496	CbGpPWpGaD
Varenicline—Angina pectoris—Liotrix—hypothyroidism	0.00375	0.00771	CcSEcCtD
Varenicline—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00374	0.00769	CcSEcCtD
Varenicline—Arrhythmia—Levothyroxine—hypothyroidism	0.00374	0.00769	CcSEcCtD
Varenicline—Bronchitis—Liotrix—hypothyroidism	0.0037	0.00761	CcSEcCtD
Varenicline—Tremor—Levothyroxine—hypothyroidism	0.00341	0.00702	CcSEcCtD
Varenicline—Tremor—Dextrothyroxine—hypothyroidism	0.00341	0.00702	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0034	0.0446	CbGpPWpGaD
Varenicline—Acute coronary syndrome—Liotrix—hypothyroidism	0.00338	0.00695	CcSEcCtD
Varenicline—Myocardial infarction—Liotrix—hypothyroidism	0.00336	0.00691	CcSEcCtD
Varenicline—Agitation—Levothyroxine—hypothyroidism	0.00335	0.00689	CcSEcCtD
Varenicline—Agitation—Dextrothyroxine—hypothyroidism	0.00335	0.00689	CcSEcCtD
Varenicline—Angioedema—Levothyroxine—hypothyroidism	0.00333	0.00685	CcSEcCtD
Varenicline—Angioedema—Dextrothyroxine—hypothyroidism	0.00333	0.00685	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00333	0.0436	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00324	0.0425	CbGpPWpGaD
Varenicline—Palpitations—Levothyroxine—hypothyroidism	0.00322	0.00662	CcSEcCtD
Varenicline—Palpitations—Dextrothyroxine—hypothyroidism	0.00322	0.00662	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00321	0.0421	CbGpPWpGaD
Varenicline—Convulsion—Dextrothyroxine—hypothyroidism	0.00316	0.00649	CcSEcCtD
Varenicline—Convulsion—Levothyroxine—hypothyroidism	0.00316	0.00649	CcSEcCtD
Varenicline—Arthralgia—Dextrothyroxine—hypothyroidism	0.0031	0.00638	CcSEcCtD
Varenicline—Arthralgia—Levothyroxine—hypothyroidism	0.0031	0.00638	CcSEcCtD
Varenicline—Anxiety—Dextrothyroxine—hypothyroidism	0.00309	0.00636	CcSEcCtD
Varenicline—Anxiety—Levothyroxine—hypothyroidism	0.00309	0.00636	CcSEcCtD
Varenicline—Hypoaesthesia—Liotrix—hypothyroidism	0.00306	0.0063	CcSEcCtD
Varenicline—Shock—Levothyroxine—hypothyroidism	0.00293	0.00602	CcSEcCtD
Varenicline—Shock—Dextrothyroxine—hypothyroidism	0.00293	0.00602	CcSEcCtD
Varenicline—Tachycardia—Dextrothyroxine—hypothyroidism	0.0029	0.00597	CcSEcCtD
Varenicline—Tachycardia—Levothyroxine—hypothyroidism	0.0029	0.00597	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—SLC5A7—hypothyroidism	0.00289	0.038	CbGpPWpGaD
Varenicline—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00287	0.00591	CcSEcCtD
Varenicline—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00287	0.00591	CcSEcCtD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00285	0.0374	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00277	0.0364	CbGpPWpGaD
Varenicline—Arrhythmia—Liotrix—hypothyroidism	0.00275	0.00566	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00274	0.036	CbGpPWpGaD
Varenicline—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00271	0.00557	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00271	0.00557	CcSEcCtD
Varenicline—Insomnia—Dextrothyroxine—hypothyroidism	0.00269	0.00553	CcSEcCtD
Varenicline—Insomnia—Levothyroxine—hypothyroidism	0.00269	0.00553	CcSEcCtD
Varenicline—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00265	0.00545	CcSEcCtD
Varenicline—Dyspnoea—Levothyroxine—hypothyroidism	0.00265	0.00545	CcSEcCtD
Varenicline—Flatulence—Liotrix—hypothyroidism	0.00264	0.00543	CcSEcCtD
Varenicline—Dysgeusia—Liotrix—hypothyroidism	0.00262	0.0054	CcSEcCtD
Varenicline—Fatigue—Dextrothyroxine—hypothyroidism	0.00256	0.00527	CcSEcCtD
Varenicline—Fatigue—Levothyroxine—hypothyroidism	0.00256	0.00527	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—SLC5A7—hypothyroidism	0.00255	0.0334	CbGpPWpGaD
Varenicline—Vision blurred—Liotrix—hypothyroidism	0.00253	0.0052	CcSEcCtD
Varenicline—Tremor—Liotrix—hypothyroidism	0.00251	0.00516	CcSEcCtD
Varenicline—Agitation—Liotrix—hypothyroidism	0.00246	0.00507	CcSEcCtD
Varenicline—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00245	0.00504	CcSEcCtD
Varenicline—Feeling abnormal—Levothyroxine—hypothyroidism	0.00245	0.00504	CcSEcCtD
Varenicline—Angioedema—Liotrix—hypothyroidism	0.00245	0.00504	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00243	0.0319	CbGpPWpGaD
Varenicline—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00243	0.005	CcSEcCtD
Varenicline—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00243	0.005	CcSEcCtD
Varenicline—Syncope—Liotrix—hypothyroidism	0.0024	0.00494	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00239	0.0314	CbGpPWpGaD
Varenicline—Palpitations—Liotrix—hypothyroidism	0.00237	0.00487	CcSEcCtD
Varenicline—Urticaria—Dextrothyroxine—hypothyroidism	0.00236	0.00486	CcSEcCtD
Varenicline—Urticaria—Levothyroxine—hypothyroidism	0.00236	0.00486	CcSEcCtD
Varenicline—Loss of consciousness—Liotrix—hypothyroidism	0.00236	0.00485	CcSEcCtD
Varenicline—Body temperature increased—Levothyroxine—hypothyroidism	0.00235	0.00484	CcSEcCtD
Varenicline—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00235	0.00484	CcSEcCtD
Varenicline—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00235	0.00484	CcSEcCtD
Varenicline—Abdominal pain—Levothyroxine—hypothyroidism	0.00235	0.00484	CcSEcCtD
Varenicline—Convulsion—Liotrix—hypothyroidism	0.00232	0.00478	CcSEcCtD
Varenicline—Hypertension—Liotrix—hypothyroidism	0.00231	0.00476	CcSEcCtD
Varenicline—Arthralgia—Liotrix—hypothyroidism	0.00228	0.00469	CcSEcCtD
Varenicline—Chest pain—Liotrix—hypothyroidism	0.00228	0.00469	CcSEcCtD
Varenicline—Anxiety—Liotrix—hypothyroidism	0.00227	0.00468	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00227	0.0298	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00219	0.0288	CbGpPWpGaD
Varenicline—Oedema—Liotrix—hypothyroidism	0.00219	0.0045	CcSEcCtD
Varenicline—Infection—Liotrix—hypothyroidism	0.00217	0.00447	CcSEcCtD
Varenicline—Shock—Liotrix—hypothyroidism	0.00215	0.00443	CcSEcCtD
Varenicline—CHRNB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00214	0.0281	CbGpPWpGaD
Varenicline—Tachycardia—Liotrix—hypothyroidism	0.00213	0.00439	CcSEcCtD
Varenicline—Asthenia—Levothyroxine—hypothyroidism	0.00213	0.00439	CcSEcCtD
Varenicline—Asthenia—Dextrothyroxine—hypothyroidism	0.00213	0.00439	CcSEcCtD
Varenicline—Hyperhidrosis—Liotrix—hypothyroidism	0.00211	0.00435	CcSEcCtD
Varenicline—Pruritus—Levothyroxine—hypothyroidism	0.0021	0.00433	CcSEcCtD
Varenicline—Pruritus—Dextrothyroxine—hypothyroidism	0.0021	0.00433	CcSEcCtD
Varenicline—Anorexia—Liotrix—hypothyroidism	0.00208	0.00429	CcSEcCtD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00205	0.0269	CbGpPWpGaD
Varenicline—Hypotension—Liotrix—hypothyroidism	0.00204	0.0042	CcSEcCtD
Varenicline—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00203	0.00418	CcSEcCtD
Varenicline—Diarrhoea—Levothyroxine—hypothyroidism	0.00203	0.00418	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00199	0.0041	CcSEcCtD
Varenicline—Insomnia—Liotrix—hypothyroidism	0.00198	0.00407	CcSEcCtD
Varenicline—Dyspnoea—Liotrix—hypothyroidism	0.00195	0.00401	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00195	0.0256	CbGpPWpGaD
Varenicline—Decreased appetite—Liotrix—hypothyroidism	0.0019	0.00391	CcSEcCtD
Varenicline—Vomiting—Levothyroxine—hypothyroidism	0.00189	0.00389	CcSEcCtD
Varenicline—Vomiting—Dextrothyroxine—hypothyroidism	0.00189	0.00389	CcSEcCtD
Varenicline—Fatigue—Liotrix—hypothyroidism	0.00189	0.00388	CcSEcCtD
Varenicline—Rash—Dextrothyroxine—hypothyroidism	0.00187	0.00386	CcSEcCtD
Varenicline—Rash—Levothyroxine—hypothyroidism	0.00187	0.00386	CcSEcCtD
Varenicline—Dermatitis—Dextrothyroxine—hypothyroidism	0.00187	0.00385	CcSEcCtD
Varenicline—Dermatitis—Levothyroxine—hypothyroidism	0.00187	0.00385	CcSEcCtD
Varenicline—Constipation—Liotrix—hypothyroidism	0.00187	0.00385	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—NEFL—hypothyroidism	0.00186	0.0245	CbGpPWpGaD
Varenicline—Headache—Dextrothyroxine—hypothyroidism	0.00186	0.00383	CcSEcCtD
Varenicline—Headache—Levothyroxine—hypothyroidism	0.00186	0.00383	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00185	0.0243	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—SLC5A7—hypothyroidism	0.00183	0.0241	CbGpPWpGaD
Varenicline—Feeling abnormal—Liotrix—hypothyroidism	0.0018	0.00371	CcSEcCtD
Varenicline—Gastrointestinal pain—Liotrix—hypothyroidism	0.00179	0.00368	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00179	0.0234	CbGpPWpGaD
Varenicline—Nausea—Dextrothyroxine—hypothyroidism	0.00177	0.00363	CcSEcCtD
Varenicline—Nausea—Levothyroxine—hypothyroidism	0.00177	0.00363	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—SLC5A7—hypothyroidism	0.00174	0.0228	CbGpPWpGaD
Varenicline—Urticaria—Liotrix—hypothyroidism	0.00174	0.00357	CcSEcCtD
Varenicline—Abdominal pain—Liotrix—hypothyroidism	0.00173	0.00356	CcSEcCtD
Varenicline—Body temperature increased—Liotrix—hypothyroidism	0.00173	0.00356	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—NEFL—hypothyroidism	0.00164	0.0215	CbGpPWpGaD
Varenicline—Hypersensitivity—Liotrix—hypothyroidism	0.00161	0.00331	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00159	0.0208	CbGpPWpGaD
Varenicline—Asthenia—Liotrix—hypothyroidism	0.00157	0.00323	CcSEcCtD
Varenicline—Pruritus—Liotrix—hypothyroidism	0.00155	0.00318	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00154	0.0202	CbGpPWpGaD
Varenicline—Diarrhoea—Liotrix—hypothyroidism	0.0015	0.00308	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00146	0.0192	CbGpPWpGaD
Varenicline—Dizziness—Liotrix—hypothyroidism	0.00145	0.00298	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—SLC5A7—hypothyroidism	0.00142	0.0186	CbGpPWpGaD
Varenicline—Vomiting—Liotrix—hypothyroidism	0.00139	0.00286	CcSEcCtD
Varenicline—Rash—Liotrix—hypothyroidism	0.00138	0.00284	CcSEcCtD
Varenicline—Dermatitis—Liotrix—hypothyroidism	0.00138	0.00283	CcSEcCtD
Varenicline—Headache—Liotrix—hypothyroidism	0.00137	0.00282	CcSEcCtD
Varenicline—Nausea—Liotrix—hypothyroidism	0.0013	0.00267	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00128	0.0168	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00119	0.0157	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—NEFL—hypothyroidism	0.00118	0.0155	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—NEFL—hypothyroidism	0.00112	0.0147	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—AVP—hypothyroidism	0.00104	0.0137	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—NEFL—hypothyroidism	0.000915	0.012	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000872	0.0114	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000711	0.00933	CbGpPWpGaD
